Drug Shortage Report for PREGABALIN

Last updated on 2018-06-30 History
Report ID 36417
Drug Identification Number 02403714
Brand name PREGABALIN
Common or Proper name PREGABALIN
Company Name SIVEM PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) PREGABALIN
Strength(s) 75MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 500
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2017-12-22
Estimated end date
Actual end date 2018-06-29
Shortage status Resolved
Updated date 2018-06-30
Company comments 500 count format not available for an extended period Will discontinue this format for the time being
Health Canada comments
Tier 3 Status No
Contact Address 4705 DOBRIN STREET
SAINT-LAURENT, QUEBEC
CANADA H4R 2P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2018-06-30 English Compare
v4 2018-06-29 French Compare
v3 2018-06-29 English Compare
v2 2018-01-18 French Compare
v1 2018-01-18 English Compare

Showing 1 to 5 of 5